SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition

作者: Liyun Miao , Yongsheng Wang , Hongping Xia , Chengyun Yao , Hourong Cai

DOI: 10.1016/J.BBRC.2013.10.024

关键词:

摘要: Lung cancer is the leading cause of related death worldwide and prognosis still poor with 5-year survival approximately 15%. Metastasis by cancer. Recent researches have demonstrated that epithelial-to-mesenchymal transition (EMT) plays a key role in early process metastasis cells. Here, we identified SPARC/osteonectin, cwcv kazal-like domains proteoglycan 1 (SPOCK1) novel transforming growth factor-β1 (TGF-β) target gene regulates lung cell EMT. TGF-β has been reported as major inductor We observed expression SPOCK1 tumor tissues significantly higher than matched normal tissues. Moreover, was also non-metastasis Levels mRNA were increased among patients shorter disease-free times, indicating potential progression metastasis. Silencing endoribonuclease-prepared small interfering RNA (esiRNA) cells inhibits growth, colony formation invasion vitro. Interestingly, ectopic epithelial induced EMT mesenchymal marker Vimentin decreased E-cadherin. found under treatment TGF-β, downstream TGF-β. Taken together, our study showed biomarker may be new diagnostic therapeutic for

参考文章(16)
Carmen Cifuentes-Diaz, Patrick M Alliel, Frédéric Charbonnier, Sabine De La Porte, Jordi Molgó, Danièle Goudou, François Rieger, Jean-Pierre Périn, Regulated expression of the proteoglycan SPOCK in the neuromuscular system. Mechanisms of Development. ,vol. 94, pp. 277- 282 ,(2000) , 10.1016/S0925-4773(00)00285-9
Yan Huang, Jing Zhang, Yuan-Yuan Zhao, Wei Jiang, Cong Xue, Fei Xu, Hong-Yun Zhao, Yang Zhang, Li-Ping Zhao, Zhi-Huang Hu, Zhi-Wen Yao, Qian-Yong Liu, Li Zhang, None, SPARC expression and prognostic value in non-small cell lung cancer Chinese Journal of Cancer. ,vol. 31, pp. 541- 548 ,(2012) , 10.5732/CJC.012.10212
Ursula Hartmann, Hanni Hülsmann, Judith Seul, Sandra Röll, Heven Midani, Isabelle Breloy, Daniel Hechler, Regina Müller, Mats Paulsson, Testican‐3: a brain‐specific proteoglycan member of the BM‐40/SPARC/osteonectin family Journal of Neurochemistry. ,vol. 125, pp. 399- 409 ,(2013) , 10.1111/JNC.12212
C Colin, N Baeza, C Bartoli, F Fina, N Eudes, I Nanni, P-m Martin, L Ouafik, D Figarella-Branger, Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization Oncogene. ,vol. 25, pp. 2818- 2826 ,(2006) , 10.1038/SJ.ONC.1209305
Heinz-J. Hausser, Ralf Decking, Rolf E. Brenner, Testican-1, an inhibitor of pro-MMP-2 activation, is expressed in cartilage. Osteoarthritis and Cartilage. ,vol. 12, pp. 870- 877 ,(2004) , 10.1016/J.JOCA.2004.07.008
Agnes Wlazlinski, Rainer Engers, Michèle J. Hoffmann, Christiane Hader, Volker Jung, Mirko Müller, Wolfgang A. Schulz, Downregulation of several fibulin genes in prostate cancer. The Prostate. ,vol. 67, pp. 1770- 1780 ,(2007) , 10.1002/PROS.20667
C. L. Chaffer, R. A. Weinberg, A Perspective on Cancer Cell Metastasis Science. ,vol. 331, pp. 1559- 1564 ,(2011) , 10.1126/SCIENCE.1203543